ALS destroys motor neurons in the brain, progressively stripping away the ability to control voluntary movement. While most people associate ALS with muscle weakness and paralysis, the disease begins in the brain’s motor cortex and spreads outward, and in many cases it reaches beyond movement to affect thinking and behavior. The brain damage in ALS is more extensive than most people realize.
How ALS Attacks the Motor Cortex
The primary target in the brain is the motor cortex, the strip of tissue that runs across the top of your head and sends signals to your muscles. ALS kills the large pyramidal neurons in layer V of this region, including specialized cells called Betz cells that are responsible for initiating voluntary movement. Studies comparing ALS brains to healthy controls show significant loss of neurons in both the primary motor cortex and, notably, the primary sensory cortex as well.
As these upper motor neurons die, the corticospinal tract, the main highway carrying movement signals from the brain down through the spinal cord, degenerates. The corpus callosum, the thick bundle of fibers connecting the brain’s two hemispheres, also shows damage. Brain imaging of ALS patients consistently reveals reduced integrity in these white matter pathways, which helps explain why symptoms can affect both sides of the body over time.
The Protein That Poisons Nerve Cells
In about 97% of ALS cases, a protein called TDP-43 behaves abnormally. This protein normally lives inside the nucleus of nerve cells, where it helps manage genetic instructions. In ALS, TDP-43 clumps together and gets displaced into the cell’s outer compartment, where it doesn’t belong. Once there, it destabilizes RNA (the messenger molecules cells use to build proteins) and disrupts the cell’s ability to manufacture what it needs to survive.
This misplaced protein doesn’t stay confined to the motor cortex. Research shows TDP-43 accumulates in a predictable sequence: it starts in the motor regions and brainstem, then spreads outward to the frontal and temporal lobes, and in advanced stages reaches the sensory areas of the parietal, temporal, and occipital lobes. This spreading pattern explains why ALS can progressively involve more of the brain as the disease advances.
Inflammation Amplifies the Damage
Motor neuron death in ALS isn’t just about the neurons themselves. The brain’s immune and support cells actively accelerate the destruction. Microglia, the brain’s resident immune cells, are among the first to respond to stressed neurons. They activate inflammatory signaling pathways and release reactive oxygen species and inflammatory molecules that damage surrounding nerve cells.
This triggers a destructive feedback loop. The inflammatory signals from microglia convert astrocytes, another type of brain support cell, into a toxic state. These reactive astrocytes then release their own harmful substances, including nitric oxide, while simultaneously sending signals back to microglia that push them toward even more aggressive inflammatory behavior. In animal models, this cross-talk between microglia and astrocytes significantly accelerates disease progression. As the disease advances, immune cells from the bloodstream also infiltrate the brain, adding further fuel to the inflammatory environment.
Cognitive and Behavioral Changes
ALS is not purely a movement disorder. Between 30% and 50% of people with ALS develop some degree of cognitive impairment, and roughly 9% to 15% eventually develop full frontotemporal dementia (FTD). A study tracking 168 individuals who initially presented with only motor symptoms found that 10% later developed measurable cognitive or behavioral changes.
The cognitive effects target specific brain regions: the cingulate gyrus, middle frontal cortex, angular gyrus, and superior and middle temporal cortex. These are areas involved in decision-making, social behavior, language, and emotional regulation. When affected, people may struggle with planning, become impulsive or apathetic, lose empathy, or develop difficulty finding words. In bulbar-onset ALS, which starts with speech and swallowing difficulties, researchers have found damage in Broca’s and Wernicke’s areas, the brain’s primary language processing regions. This pattern of damage is not typically seen in limb-onset cases.
What the Brain Regions Look Like in Different Types
ALS generally comes in two forms based on where symptoms first appear: bulbar onset (starting with speech and swallowing problems) and spinal onset (starting with limb weakness). Both types show neuronal loss, spongy tissue changes, and abnormal protein deposits in the motor cortex, frontotemporal regions, deep brain structures, and the cerebellum. But bulbar-onset ALS tends to produce more widespread and sometimes atypical brain pathology, including neurofibrillary tangles and unusual protein deposits that don’t appear in spinal-onset cases.
What ALS Tends to Spare
Despite its devastating reach, ALS leaves certain brain functions relatively intact. Eye movements remain functional in most patients well into advanced disease, which is why eye-tracking communication devices work so effectively. Sensory perception, including touch, temperature, and pain, is largely preserved for most of the disease course, though sensory brain responses do eventually diminish in late stages as TDP-43 pathology spreads to sensory cortical areas.
Autonomic brain centers, the regions controlling heart rate, blood pressure, and digestion, are also mostly spared. The brainstem nuclei responsible for basic autonomic regulation remain structurally intact in ALS. That said, some patients do experience cardiovascular changes in advanced disease, likely due to impairment of central sympathetic mechanisms rather than damage to the primary autonomic control centers themselves.
How Quickly Brain Damage Progresses
ALS is one of the fastest-progressing neurodegenerative diseases. Median survival from diagnosis is 2 to 4 years, with one large cohort study finding a median of 2.2 years. Between 5% and 15% of people survive significantly longer, with long-term survivors reaching a median of 13.4 years. The speed of brain involvement varies: some people maintain full cognitive function throughout, while others develop noticeable thinking or behavioral changes within the first year or two. Bulbar-onset ALS generally progresses faster than limb-onset, and the presence of cognitive changes is associated with a worse prognosis.
Diagnosis now relies on the Gold Coast Criteria, which have a sensitivity of about 95% for identifying ALS. This is a major improvement over older diagnostic systems, which caught only 54% to 59% of cases at the “probable” level. Earlier recognition means earlier confirmation, though the trade-off is a somewhat higher rate of initial misdiagnosis in settings where ALS is uncommon.